Biogen's $85 Million Deal Could Change How Patients Get Spinraza Treatment

benzinga.com/m-a/25/09/47748035/biogens-85-million-deal-could-change-how-patients-get-spinraza-treatment

Biogen Inc. (NASDAQ:BIIB) on Thursday agreed to acquire Massachusetts-based Alcyone Therapeutics for $85 million.
Alcyone will also receive certain milestones payable related to the development and regulatory approval of ThecaFlex DRx with nusinersen and additional pipeline products,…

This story appeared on benzinga.com, 2025-09-18 18:12:22.
The Entire Business World on a Single Page. Free to Use →